Concord Wealth Partners Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Concord Wealth Partners reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% in the 2nd quarter, Holdings Channel.com reports. The fund owned 5,137 shares of the healthcare conglomerate’s stock after selling 313 shares during the quarter. Concord Wealth Partners’ holdings in UnitedHealth Group were worth $1,603,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Nabity Jensen Investment Management Inc lifted its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after acquiring an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC grew its position in UnitedHealth Group by 8.9% during the 1st quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 25 shares in the last quarter. Stewardship Advisors LLC lifted its stake in shares of UnitedHealth Group by 4.1% in the first quarter. Stewardship Advisors LLC now owns 663 shares of the healthcare conglomerate’s stock valued at $347,000 after buying an additional 26 shares during the period. Osborne Partners Capital Management LLC lifted its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock valued at $558,000 after buying an additional 26 shares during the period. Finally, HHM Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 3.6%

Shares of UnitedHealth Group stock opened at $354.30 on Monday. The business has a fifty day simple moving average of $318.21 and a 200 day simple moving average of $348.08. The stock has a market cap of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on UNH. KeyCorp raised their price objective on shares of UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Royal Bank Of Canada lowered their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a report on Wednesday, October 8th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.